Consolidated Water

Company CWCO

Last mentioned: Mar 16, 2026

Stories mentioning Consolidated Water 2

earnings Neutral

Abeona and Consolidated Water Set for FY 2025 Results Amid Sector Shifts

Abeona Therapeutics and Consolidated Water are preparing to report full-year 2025 financial results, highlighting contrasting paths in the biotech and utility sectors. While Abeona faces critical regulatory milestones for its gene therapy pipeline, Consolidated Water continues to leverage infrastructure expansion to drive steady revenue growth.

2 sources
market-trends Neutral

Abeona Therapeutics FY 2025 Preview: ZEVASKYN® Commercial Execution in Focus

Abeona Therapeutics is set to report its fiscal year 2025 results, marking its transition from a clinical-stage developer to a commercial-stage biopharmaceutical entity. The primary focus for investors is the commercial trajectory of ZEVASKYN® for recessive dystrophic epidermolysis bullosa (RDEB) and the company's ability to manage complex cell therapy logistics.

2 sources